These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2770120)

  • 21. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
    Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA
    Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
    Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
    Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
    Brunner H; Mann H; Stiller S; Sieberth HG
    Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
    [No Abstract]   [Full Text] [Related]  

  • 27. Fresenius Polysulfone--membrane developments to meet clinical demands.
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S1-60. PubMed ID: 7923976
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
    Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
    Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers.
    Albright RC; Smelser JM; McCarthy JT; Homburger HA; Bergstralh EJ; Larson TS
    Mayo Clin Proc; 2000 Nov; 75(11):1141-7. PubMed ID: 11075743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced iopromide elimination in hemodialysis with cuprophan membranes.
    Matzkies FK; Reinecke H; Tombach B; Koeneke J; Hohage H; Kisters K; Schaefer RM
    Acta Radiol; 2000 Nov; 41(6):671-3. PubMed ID: 11092496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of polysulfone and hemophan hemodialysis membranes on phagocytes.
    Kubala L; Cíz M; Soska V; Cerný J; Lojek A
    Gen Physiol Biophys; 2002 Dec; 21(4):367-80. PubMed ID: 12693710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
    Agarwal R; Cronin RE
    Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis.
    Hartmann J; Fricke H; Schiffl H
    Am J Kidney Dis; 1997 Sep; 30(3):366-73. PubMed ID: 9292565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers.
    Hsu HJ; Chen CK; Wu MS
    Am J Nephrol; 2009; 29(6):592-7. PubMed ID: 19145074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
    Liszka M; Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z
    Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers.
    Gabutti L; Taminelli-Beltraminelli L; Marone C
    Eur J Clin Pharmacol; 1997; 53(2):123-6. PubMed ID: 9403283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of polysulfone membrane dialyzers and dialysate flow pattern.
    Nakashima A; Ogata S; Doi S; Yamahira M; Naraki S; Takasugi N; Ohmoto T; Ito T; Masaki T; Yorioka N
    Clin Exp Nephrol; 2006 Sep; 10(3):210-5. PubMed ID: 17009079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.